| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $85.2M | +26.2% |
| Cost of Revenue | $41.3M | +24.6% |
| Gross Profit | $43.9M | +27.7% |
| R&D Expense | $33.1M | +61.2% |
| SG&A Expense | $23.5M | +81.9% |
| Operating Income | -$48.1M | -156.0% |
| Interest Expense | $4.3M | +16.6% |
| Pre-tax Income | -$51.4M | -138.0% |
| Income Tax | -$39K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.7M | -93.6% |
| Short-term Investments | $58.7M | — |
| Accounts Receivable | $856K | +177.0% |
| Current Assets | $74.4M | -33.0% |
| Total Assets | $152.5M | -6.8% |
| Current Liabilities | $56.3M | +24.9% |
| Total Liabilities | $83.7M | +22.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.8M | -491.5% |
| Capital Expenditures | $7.3M | -3.0% |
| Investing Cash Flow | -$73.9M | -560.0% |
| Financing Cash Flow | -$6.2M | -105.8% |
| Free Cash Flow | -$21.1M | -420.6% |
| -140.6% |
| Net Income | -$51.4M | -136.8% |
| EPS (Basic) | -$1.62 | -51.4% |
| EPS (Diluted) | -$1.62 | -51.4% |
| Stockholders' Equity |
| $68.7M |
| -28.0% |